Cited by 498CRISPR and Genetic EngineeringBacterial Genetics and BiotechnologyBiochemical and Structural Characterization

Classification and evolution of type II CRISPR-Cas systems

Open access
Chylinski, Krzysztof, Makarova, Kira S., Charpentier, Emmanuelle, Koonin, Eugene V.·2014·Nucleic Acids Research

Abstract

The CRISPR-Cas systems of archaeal and bacterial adaptive immunity are classified into three types that differ by the repertoires of CRISPR-associated (cas) genes, the organization of cas operons and the structure of repeats in the CRISPR arrays. The simplest among the CRISPR-Cas systems is type II in which the endonuclease activities required for the interference with foreign deoxyribonucleic acid (DNA) are concentrated in a single multidomain protein, Cas9, and are guided by a co-processed dual-tracrRNA:crRNA molecule. This compact enzymatic machinery and readily programmable site-specific DNA targeting make type II systems top candidates for a new generation of powerful tools for genomic engineering. Here we report an updated census of CRISPR-Cas systems in bacterial and archaeal genomes. Type II systems are the rarest, missing in archaea, and represented in ∼ 5% of bacterial genomes, with an over-representation among pathogens and commensals. Phylogenomic analysis suggests that at least three cas genes, cas1, cas2 and cas4, and the CRISPR repeats of the type II-B system were acquired via recombination with a type I CRISPR-Cas locus. Distant homologs of Cas9 were identified among proteins encoded by diverse transposons, suggesting that type II CRISPR-Cas evolved via recombination of mobile nuclease genes with type I loci.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gku241

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Due to recognition preference of some specific bases of CRISPR/Cas9 system and diverse epigenetic landscape, different targeted gene loci may exhibit distinctive different gene editing efficiencies.

    “Besides, due to the recognition preference of some specific bases of CRISPR/Cas9 system and the diverse epigenetic landscape, different targeted gene loci may exhibit distinctive different gene editing efficiencies [140, 201–203].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 84 · Cited by 498

Authors
Chylinski, K., Makarova, K. S., Charpentier, E., & Koonin, E. V.
Affiliations
  • University of Vienna (AT)
  • National Institutes of Health (US)
  • Medizinische Hochschule Hannover (DE)
Corresponding author
Koonin, Eugene V.
Venue
Nucleic Acids Research
Published
2014-04-11
Volume
42
Issue
10
Pages
6091-6105
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2133908827
Cited by
498
References
84
Citations by year
2026: 18 · 2025: 40 · 2024: 49 · 2023: 45 · 2022: 45 · 2021: 45 · 2020: 35 · 2019: 41 · 2018: 36 · 2017: 48 · 2016: 37 · 2015: 43 · 2014: 14 · 2013: 1
FWCI
4.46
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • Nucleic Acids Research (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Health and Human Services
  • Alexander von Humboldt-Stiftung
  • Kempe Foundation
  • Bundesministerium für Bildung und Forschung
  • Vetenskapsrådet (K2013-57X-21436-04-3)
  • Umeå Universitet
  • Umeå Centre for Microbial Research
  • U.S. National Library of Medicine
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
Keywords
Cas9, type I CRISPR-Cas, Cas1, Cas2, adaptive immunity, archaea, bacteria, phylogenomics, horizontal gene transfer, genomic engineering
MeSH terms
Endonucleases, Phylogeny, Genome, Bacterial, Evolution, Molecular, Genome, Archaeal, CRISPR-Cas Systems, CRISPR-Associated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review